Knight Therapeutics | GUD - Market Capitalization

Stock Price
6.18
Daily Change
0.04 0.65%
Monthly
-5.65%
Yearly
-0.16%
Q1 Forecast
5.95

Knight Therapeutics reported CAD627.26M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 502M 75M Mar/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 781.35M 426.11M Sep/2025
Cronos Group USD 1B 55.93M Dec/2025
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Knight Therapeutics CAD 624.22M 38.25M Mar/2026
Organigram Holdings CAD 378.8M 132.2M Sep/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.32B 562M Sep/2025